Chemical exposures, such as arsenic in drinking water, tar, or working with insecticides or herbicides. N0: no regional lymph node metastasis. Organizations who contract with CMS acknowledge that they may have a commercial CDT license with the ADA, and that use of CDT codes as permitted herein for the administration of CMS programs does not extend to any other programs or services the organization may administer and royalties dues for the use of the CDT codes are governed by their commercial license. Articles often contain coding or other guidelines that are related to a Local Coverage Determination (LCD). Primary squamous-cell carcinoma of the thyroid shows an aggressive biological phenotype . without the written consent of the AHA. Absence of a Bill Type does not guarantee that the 2023 ICD-10-CM Diagnosis Code D04.9 - ICD10Data.com "JavaScript" disabled. The AMA is a third party beneficiary to this Agreement. Carcinoma In situ. 2. An official website of the United States government. Billing and Coding articles typically include CPT/HCPCS procedure codes, ICD-10-CM diagnosis codes, as well as Bill Type, Revenue, and CPT/HCPCS Modifier codes. [/QUOTE] FAQ icd 10 code for basal cell carcinoma of nose What is the ICD 10 for basal cell carcinoma of skin? Chapter 2 classifies neoplasms primarily by site (topography), with broad groupings for behavior, malignant, in situ, benign, etc. Treatment of squamous cell carcinoma in situ: a review Refer to the LCD for reasonable and necessary requirements and limitations. used to report this service. Instructions for enabling "JavaScript" can be found here. GOVERNMENT AND ITS EMPLOYEES ARE NOT LIABLE FOR ANY ERRORS, OMISSIONS, OR OTHER INACCURACIES IN THE INFORMATION, PRODUCT, OR PROCESSES To submit a comment or question to CMS, please use the Feedback/Ask a Question link available at the bottom Curettage and electrodessication (C and E). Check out the dx block of D04.4. Before sharing sensitive information, make sure you're on a federal government site. The term carcinoma in situ (or CIS) . The Table of Neoplasms should be used to identify the correct topography code. Best way to code an invasive and in situ breast carcinoma Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not Use of CDT is limited to use in programs administered by Centers for Medicare & Medicaid Services (CMS). If you are a particularly observant medical coder you8217ve probably noticed that many codes identified as deleted were actually promoted to new roles. Medicare contractors are required to develop and disseminate Articles. Tis: carcinoma in situ. Medicaid and the State Children's Health Insurance Programs, contracts with certain organizations to assist in the administration that coverage is not influenced by Bill Type and the article should be assumed to This common malignancy is primarily seen in older adults and most frequently occurs on sun-exposed skin. In most instances Revenue Codes are purely advisory. Therefore, if a drug is self-administered by more than 50 percent of Medicare beneficiaries, the drug is excluded from coverage" and the MAC will make no payment for the drug. In most instances Revenue Codes are purely advisory. Request a Demo 14 Day Free Trial Buy Now Official Long Descriptor Conjunctival squamous cell carcinoma - Wikipedia You can collapse such groups by clicking on the group header to make navigation easier. The submitted CPT/HCPCS code must describe the service performed. End User License Agreement: Tanning bed use. You acknowledge that the ADA holds all copyright, trademark and other rights in CDT. article does not apply to that Bill Type. Icd 10 code for basal cell carcinoma of nose Updated Morphology & Grade | SEER Training - National Cancer Institute The medical record/ progress note should indicate the removal of a malignant or an ambiguous, but moderate to high suspicion lesion with a corresponding pathology report.The size and location of the lesion should be documented in the operative report. hbbd```b``+A$S2Xd,@$k5XDO0y LlU@&0&y*&F`I 30,` VF Medicare Telehealth Coding as of April 30, Failure to Approve Proton Tx Costs Aetna $25 M, MIPS Quality Measures Affected by ICD-10 Update. You agree to take all necessary steps to insure that your employees and agents abide by the terms of this agreement. 23. ICD-10-CM Coding instruction note: Excludes familial polycythemia (C75.0), secondary polycythemia (D75.1) D46.- Myelodysplastic syndromes . C44.42 Squamous cell carcinoma of skin of scalp and neck If you do not agree with all terms and conditions set forth herein, click below on the button labeled "I do not accept" and exit from this computer screen. presented in the material do not necessarily represent the views of the AHA. Squamous cell carcinoma in situ - VisualDx No portion of the American Hospital Association (AHA) copyrighted materials contained within this publication may be Complete absence of all Revenue Codes indicates For multiple neoplasms of the same site that are not contiguous, such as tumors in different quadrants of the same breast, codes for each site should be assigned. preparation of this material, or the analysis of information provided in the material. authorized with an express license from the American Hospital Association. damages arising out of the use of such information, product, or process. Please do not use this feature to contact CMS. authorized with an express license from the American Hospital Association. If you are acting on behalf of an organization, you represent that you are authorized to act on behalf of such organization and that your acceptance of the terms of this agreement creates a legally enforceable obligation of the organization. The Table of Neoplasms should be used to identify the correct topography code. #2. due to the exclude 1 note you do not code the C50 code with the D05 code so code only the invasive. If you would like to extend your session, you may select the Continue Button. M0: no clinical or radiographic evidence of distant metastasis. Request a Demo 14 Day Free Trial Buy Now Official Long Descriptor Carcinoma in situ of skin Excludes1: erythroplasia of Queyrat (penis) NOS ( D07.4) You are leaving the CMS MCD and are being redirected to the CMS MCD Archive that contains outdated (No Longer In Effect) Local Coverage Determinations and Articles, You are leaving the CMS MCD and are being redirected to, Billing and Coding: Excision of Malignant Skin Lesions, AMA CPT / ADA CDT / AHA NUBC Copyright Statement, Article - Billing and Coding: Excision of Malignant Skin Lesions (A57660). For example, there is no way in ICD to distinguish between an adenocarcinoma of the lung and a squamous cell carcinoma of the lung: both would be coded to C34.9. Malignant neoplasms of ectopic tissue are to be coded to the site mentioned, e.g., ectopic pancreatic malignant neoplasms are coded to pancreas, unspecified (. without the written consent of the AHA. C44.62- Squamous cell carcinoma of skin of upper limb, including shoulder These abnormal cells may become cancer and spread into nearby normal tissue. As a contributor you will produce quality content for the business of healthcare, taking the Knowledge Center forward with your knowhow and expertise. Carcinoma - Wikipedia As used herein, "you" and "your" refer to you and any organization on behalf of which you are acting. Sometimes, a large group can make scrolling thru a document unwieldy. Any questions pertaining to the license or use of the CPT should be addressed to the AMA. Your MCD session is currently set to expire in 5 minutes due to inactivity. Location. C34 Malignant neoplasm of the bronchi and lung. Key words: C44.92 Squamous cell carcinoma of skin, unspecified Note: . Local Coverage Articles are a type of educational document published by the Medicare Administrative Contractors (MACs). When a lesion is excised that is a neoplasm of uncertain morphology (e.g., melanoma vs. dyplastic nevi), choose the correct CPT code based on the manner in which the lesion is excised rather than the final pathological diagnosis. OPSCC cases were defined using the following International Classification of Disease for Oncology (ICD-O-3) site codes: base of tongue (C01.9 . Neither the United States Government nor its employees represent that use of such information, product, or processes All rights reserved. ICD-10 code D04 for Carcinoma in situ of skin is a medical classification as listed by WHO under the range - Neoplasms . S. There are 90 terms under the parent term 'Carcinoma In Situ' in the ICD-10-CM Alphabetical Index . The views and/or positions The AMA does not directly or indirectly practice medicine or dispense medical services. By clicking below on the button labeled "I accept", you hereby acknowledge that you have read, understood and agreed to all terms and conditions set forth in this agreement. The Centers for Medicare & Medicaid Services (CMS), the federal agency responsible for administration of the Medicare, When billing for non-covered services, use the appropriate modifier. 625 0 obj <>/Filter/FlateDecode/ID[<300BF5E799812D49BBFB4D9A3883AA65>]/Index[604 32]/Info 603 0 R/Length 104/Prev 172627/Root 605 0 R/Size 636/Type/XRef/W[1 3 1]>>stream Per the 2020 ICD-10 guidelines, 'consistent with D04.4 would be incorrect as this is documented neither [I]in situ [/I]nor as a carcinoma of the skin. CMS DISCLAIMS RESPONSIBILITY FOR ANY LIABILITY ATTRIBUTABLE TO END USER USE OF THE CPT. This is the American ICD-10-CM version of D04.9 - other international versions of ICD-10 D04.9 may differ. It is important to remember when accessing the Neoplasm Table, to look under the main term Skin, first, then drop to the body part, to locate the appropriate code. malignant, in situ, benign, etc. Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes. In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes. All documentation must be maintained in the patient's medical record and made available to the contractor upon request. Draft articles have document IDs that begin with "DA" (e.g., DA12345). The Centers for Medicare 38 Medicaid Services CMS has identified four quality measures impacted by the Oct. 1 update to the ICD10CM code set. Squamous cell carcinoma pathology | DermNet Squamous cell carcinoma (80703) Occurs in 8% of all bladder carcinomas. If an entity wishes to utilize any AHA materials, please contact the AHA at 312‐893‐6816. Cutaneous SCC is an invasive disease, referring to cancer cells that have grown beyond the epidermis. endstream endobj startxref Objectives: To determine patient and disease characteristics, treatment patterns and long-term outcomes, in order to help direct management of patients with VIN 3, to examine the risk of development of cancer following a diagnosis of VIN 3 and the risk of recurrent disease requiring multiple treatment episodes, and to review patients with vulval cancer, in order to establish the relative . Chapter 2 classifies neoplasms primarily by site (topography), with broad groupings for behavior, malignant, in situ, benign, etc. proven squamous cell carcinoma on his back. Applicable FARS\DFARS Restrictions Apply to Government Use. Adenocarcinoma (81403) of the bladder Very rare (2%) and almost impossible to distinguish from primary prostate carcinoma which has extended into the bladder. This type of excision would be most appropriately reported using the excision of malignant lesion including margins codes 11600- 11646. Other risk factors for SCC include: To assign the most appropriate ICD-10-CM code for squamous cell carcinoma, clinical documentation should indicate: ICD-10-CM chapter 2 contains codes for most benign and malignant neoplasms. Please enable "JavaScript" and revisit this page or proceed with browsing CMS.gov with Check out the dx block of D04.4. Response to Comment (RTC) articles list issues raised by external stakeholders during the Proposed LCD comment period. American Hospital Association ("AHA"), Carcinoma in situ of skin of eyelid, including canthus, Carcinoma in situ of skin of ear and external auricular canal, Carcinoma in situ of skin of other and unspecified parts of face, Carcinoma in situ of skin of scalp and neck, Carcinoma in situ of skin of upper limb, including shoulder, Carcinoma in situ of skin of lower limb, including hip. In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes. Please note that if you choose to continue without enabling "JavaScript" certain functionalities on this website may not be available. ICD 10 code for Squamous cell carcinoma of skin of upper limb, including shoulder. If you do not agree with all terms and conditions set forth herein, click below on the button labeled "I do not accept" and exit from this computer screen. 9: Squamous cell carcinoma of the anus, NOS Squamous cell carcinoma of the anus (C210) is reportable. ICD-10-CM Codes that Support Medical Necessity, ICD-10-CM Codes that DO NOT Support Medical Necessity, L33818 - Excision of Malignant Skin Lesions, EXCISION, MALIGNANT LESION INCLUDING MARGINS, TRUNK, ARMS, OR LEGS; EXCISED DIAMETER 0.5 CM OR LESS, EXCISION, MALIGNANT LESION INCLUDING MARGINS, TRUNK, ARMS, OR LEGS; EXCISED DIAMETER 0.6 TO 1.0 CM, EXCISION, MALIGNANT LESION INCLUDING MARGINS, TRUNK, ARMS, OR LEGS; EXCISED DIAMETER 1.1 TO 2.0 CM, EXCISION, MALIGNANT LESION INCLUDING MARGINS, TRUNK, ARMS, OR LEGS; EXCISED DIAMETER 2.1 TO 3.0 CM, EXCISION, MALIGNANT LESION INCLUDING MARGINS, TRUNK, ARMS, OR LEGS; EXCISED DIAMETER 3.1 TO 4.0 CM, EXCISION, MALIGNANT LESION INCLUDING MARGINS, TRUNK, ARMS, OR LEGS; EXCISED DIAMETER OVER 4.0 CM, EXCISION, MALIGNANT LESION INCLUDING MARGINS, SCALP, NECK, HANDS, FEET, GENITALIA; EXCISED DIAMETER 0.5 CM OR LESS, EXCISION, MALIGNANT LESION INCLUDING MARGINS, SCALP, NECK, HANDS, FEET, GENITALIA; EXCISED DIAMETER 0.6 TO 1.0 CM, EXCISION, MALIGNANT LESION INCLUDING MARGINS, SCALP, NECK, HANDS, FEET, GENITALIA; EXCISED DIAMETER 1.1 TO 2.0 CM, EXCISION, MALIGNANT LESION INCLUDING MARGINS, SCALP, NECK, HANDS, FEET, GENITALIA; EXCISED DIAMETER 2.1 TO 3.0 CM, EXCISION, MALIGNANT LESION INCLUDING MARGINS, SCALP, NECK, HANDS, FEET, GENITALIA; EXCISED DIAMETER 3.1 TO 4.0 CM, EXCISION, MALIGNANT LESION INCLUDING MARGINS, SCALP, NECK, HANDS, FEET, GENITALIA; EXCISED DIAMETER OVER 4.0 CM, EXCISION, MALIGNANT LESION INCLUDING MARGINS, FACE, EARS, EYELIDS, NOSE, LIPS; EXCISED DIAMETER 0.5 CM OR LESS, EXCISION, MALIGNANT LESION INCLUDING MARGINS, FACE, EARS, EYELIDS, NOSE, LIPS; EXCISED DIAMETER 0.6 TO 1.0 CM, EXCISION, MALIGNANT LESION INCLUDING MARGINS, FACE, EARS, EYELIDS, NOSE, LIPS; EXCISED DIAMETER 1.1 TO 2.0 CM, EXCISION, MALIGNANT LESION INCLUDING MARGINS, FACE, EARS, EYELIDS, NOSE, LIPS; EXCISED DIAMETER 2.1 TO 3.0 CM, EXCISION, MALIGNANT LESION INCLUDING MARGINS, FACE, EARS, EYELIDS, NOSE, LIPS; EXCISED DIAMETER 3.1 TO 4.0 CM, EXCISION, MALIGNANT LESION INCLUDING MARGINS, FACE, EARS, EYELIDS, NOSE, LIPS; EXCISED DIAMETER OVER 4.0 CM, Malignant melanoma of other part of trunk, Malignant melanoma of unspecified upper limb, including shoulder, Malignant melanoma of right upper limb, including shoulder, Malignant melanoma of left upper limb, including shoulder, Malignant melanoma of unspecified lower limb, including hip, Malignant melanoma of right lower limb, including hip, Malignant melanoma of left lower limb, including hip, Merkel cell carcinoma of other part of trunk, Merkel cell carcinoma of unspecified upper limb, including shoulder, Merkel cell carcinoma of right upper limb, including shoulder, Merkel cell carcinoma of left upper limb, including shoulder, Merkel cell carcinoma of unspecified lower limb, including hip, Merkel cell carcinoma of right lower limb, including hip, Merkel cell carcinoma of left lower limb, including hip, Unspecified malignant neoplasm of anal skin, Unspecified malignant neoplasm of skin of breast, Unspecified malignant neoplasm of skin of other part of trunk, Basal cell carcinoma of skin of other part of trunk, Squamous cell carcinoma of skin of breast, Squamous cell carcinoma of skin of other part of trunk, Other specified malignant neoplasm of anal skin, Other specified malignant neoplasm of skin of breast, Other specified malignant neoplasm of skin of other part of trunk, Unspecified malignant neoplasm of skin of unspecified upper limb, including shoulder, Unspecified malignant neoplasm of skin of right upper limb, including shoulder, Unspecified malignant neoplasm of skin of left upper limb, including shoulder, Basal cell carcinoma of skin of unspecified upper limb, including shoulder, Basal cell carcinoma of skin of right upper limb, including shoulder, Basal cell carcinoma of skin of left upper limb, including shoulder, Squamous cell carcinoma of skin of unspecified upper limb, including shoulder, Squamous cell carcinoma of skin of right upper limb, including shoulder, Squamous cell carcinoma of skin of left upper limb, including shoulder, Other specified malignant neoplasm of skin of unspecified upper limb, including shoulder, Other specified malignant neoplasm of skin of right upper limb, including shoulder, Other specified malignant neoplasm of skin of left upper limb, including shoulder, Unspecified malignant neoplasm of skin of unspecified lower limb, including hip, Unspecified malignant neoplasm of skin of right lower limb, including hip, Unspecified malignant neoplasm of skin of left lower limb, including hip, Basal cell carcinoma of skin of unspecified lower limb, including hip, Basal cell carcinoma of skin of right lower limb, including hip, Basal cell carcinoma of skin of left lower limb, including hip, Squamous cell carcinoma of skin of unspecified lower limb, including hip, Squamous cell carcinoma of skin of right lower limb, including hip, Squamous cell carcinoma of skin of left lower limb, including hip, Other specified malignant neoplasm of skin of unspecified lower limb, including hip, Other specified malignant neoplasm of skin of right lower limb, including hip, Other specified malignant neoplasm of skin of left lower limb, including hip, Malignant neoplasm of unspecified upper limb, Malignant neoplasm of unspecified lower limb, Malignant neoplasm of other specified ill-defined sites, Melanoma in situ of breast (skin) (soft tissue), Melanoma in situ of unspecified upper limb, including shoulder, Melanoma in situ of right upper limb, including shoulder, Melanoma in situ of left upper limb, including shoulder, Melanoma in situ of unspecified lower limb, including hip, Melanoma in situ of right lower limb, including hip, Melanoma in situ of left lower limb, including hip, Carcinoma in situ of skin of unspecified upper limb, including shoulder, Carcinoma in situ of skin of right upper limb, including shoulder, Carcinoma in situ of skin of left upper limb, including shoulder, Carcinoma in situ of skin of unspecified lower limb, including hip, Carcinoma in situ of skin of right lower limb, including hip, Carcinoma in situ of skin of left lower limb, including hip, Unspecified malignant neoplasm of skin of scalp and neck, Basal cell carcinoma of skin of scalp and neck, Squamous cell carcinoma of skin of scalp and neck, Other specified malignant neoplasm of skin of scalp and neck, Malignant neoplasm of overlapping sites of vulva, Malignant neoplasm of other specified female genital organs, Malignant neoplasm of overlapping sites of female genital organs, Malignant neoplasm of overlapping sites of penis, Malignant neoplasm of head, face and neck, Secondary malignant neoplasm of genital organs, Carcinoma in situ of skin of scalp and neck, Carcinoma in situ of unspecified female genital organs, Carcinoma in situ of other female genital organs, Carcinoma in situ of unspecified male genital organs, Carcinoma in situ of other male genital organs, Malignant neoplasm of external lip, unspecified, Malignant neoplasm of upper lip, inner aspect, Malignant neoplasm of lower lip, inner aspect, Malignant neoplasm of lip, unspecified, inner aspect, Malignant neoplasm of commissure of lip, unspecified, Malignant neoplasm of overlapping sites of lip, Malignant neoplasm of dorsal surface of tongue, Malignant neoplasm of ventral surface of tongue, Malignant neoplasm of anterior two-thirds of tongue, part unspecified, Malignant neoplasm of overlapping sites of tongue, Malignant neoplasm of tongue, unspecified, Malignant neoplasm of anterior floor of mouth, Malignant neoplasm of lateral floor of mouth, Malignant neoplasm of overlapping sites of floor of mouth, Malignant neoplasm of floor of mouth, unspecified, Malignant neoplasm of overlapping sites of palate, Malignant neoplasm of palate, unspecified, Malignant neoplasm of overlapping sites of unspecified parts of mouth, Malignant neoplasm of overlapping sites of other parts of mouth, Malignant neoplasm of submandibular gland, Malignant neoplasm of major salivary gland, unspecified, Malignant neoplasm of tonsillar pillar (anterior) (posterior), Malignant neoplasm of overlapping sites of tonsil, Malignant neoplasm of tonsil, unspecified, Malignant neoplasm of anterior surface of epiglottis, Malignant neoplasm of lateral wall of oropharynx, Malignant neoplasm of posterior wall of oropharynx, Malignant neoplasm of overlapping sites of oropharynx, Malignant neoplasm of oropharynx, unspecified, Malignant neoplasm of superior wall of nasopharynx, Malignant neoplasm of posterior wall of nasopharynx, Malignant neoplasm of lateral wall of nasopharynx, Malignant neoplasm of anterior wall of nasopharynx, Malignant neoplasm of overlapping sites of nasopharynx, Malignant neoplasm of nasopharynx, unspecified, Malignant neoplasm of aryepiglottic fold, hypopharyngeal aspect, Malignant neoplasm of posterior wall of hypopharynx, Malignant neoplasm of overlapping sites of hypopharynx, Malignant neoplasm of hypopharynx, unspecified, Malignant neoplasm of pharynx, unspecified, Malignant neoplasm of overlapping sites of lip, oral cavity and pharynx, Malignant melanoma of unspecified eyelid, including canthus, Malignant melanoma of right upper eyelid, including canthus, Malignant melanoma of right lower eyelid, including canthus, Malignant melanoma of left upper eyelid, including canthus, Malignant melanoma of left lower eyelid, including canthus, Malignant melanoma of unspecified ear and external auricular canal, Malignant melanoma of right ear and external auricular canal, Malignant melanoma of left ear and external auricular canal, Malignant melanoma of unspecified part of face, Malignant melanoma of other parts of face, Malignant melanoma of overlapping sites of skin, Merkel cell carcinoma of unspecified eyelid, including canthus, Merkel cell carcinoma of right upper eyelid, including canthus, Merkel cell carcinoma of right lower eyelid, including canthus, Merkel cell carcinoma of left upper eyelid, including canthus, Merkel cell carcinoma of left lower eyelid, including canthus, Merkel cell carcinoma of unspecified ear and external auricular canal, Merkel cell carcinoma of right ear and external auricular canal, Merkel cell carcinoma of left ear and external auricular canal, Merkel cell carcinoma of unspecified part of face, Merkel cell carcinoma of other parts of face, Merkel cell carcinoma of overlapping sites, Unspecified malignant neoplasm of skin of lip, Other specified malignant neoplasm of skin of lip, Unspecified malignant neoplasm of skin of unspecified eyelid, including canthus, Unspecified malignant neoplasm of skin of right upper eyelid, including canthus, Unspecified malignant neoplasm of skin of right lower eyelid, including canthus, Unspecified malignant neoplasm of skin of left upper eyelid, including canthus, Unspecified malignant neoplasm of skin of left lower eyelid, including canthus, Basal cell carcinoma of skin of unspecified eyelid, including canthus, Basal cell carcinoma of skin of right upper eyelid, including canthus, Basal cell carcinoma of skin of right lower eyelid, including canthus, Basal cell carcinoma of skin of left upper eyelid, including canthus, Basal cell carcinoma of skin of left lower eyelid, including canthus, Squamous cell carcinoma of skin of unspecified eyelid, including canthus, Squamous cell carcinoma of skin of right upper eyelid, including canthus, Squamous cell carcinoma of skin of right lower eyelid, including canthus, Squamous cell carcinoma of skin of left upper eyelid, including canthus, Squamous cell carcinoma of skin of left lower eyelid, including canthus, Sebaceous cell carcinoma of skin of unspecified eyelid, including canthus, Sebaceous cell carcinoma of skin of right upper eyelid, including canthus, Sebaceous cell carcinoma of skin of right lower eyelid, including canthus, Sebaceous cell carcinoma of skin of left upper eyelid, including canthus, Sebaceous cell carcinoma of skin of left lower eyelid, including canthus, Other specified malignant neoplasm of skin of unspecified eyelid, including canthus, Other specified malignant neoplasm of skin of right upper eyelid, including canthus, Other specified malignant neoplasm of skin of right lower eyelid, including canthus, Other specified malignant neoplasm of skin of left upper eyelid, including canthus, Other specified malignant neoplasm of skin of left lower eyelid, including canthus, Unspecified malignant neoplasm of skin of unspecified ear and external auricular canal, Unspecified malignant neoplasm of skin of right ear and external auricular canal, Unspecified malignant neoplasm of skin of left ear and external auricular canal, Basal cell carcinoma of skin of unspecified ear and external auricular canal, Basal cell carcinoma of skin of right ear and external auricular canal, Basal cell carcinoma of skin of left ear and external auricular canal, Squamous cell carcinoma of skin of unspecified ear and external auricular canal, Squamous cell carcinoma of skin of right ear and external auricular canal, Squamous cell carcinoma of skin of left ear and external auricular canal, Other specified malignant neoplasm of skin of unspecified ear and external auricular canal, Other specified malignant neoplasm of skin of right ear and external auricular canal, Other specified malignant neoplasm of skin of left ear and external auricular canal, Unspecified malignant neoplasm of skin of unspecified part of face, Unspecified malignant neoplasm of skin of nose, Unspecified malignant neoplasm of skin of other parts of face, Basal cell carcinoma of skin of unspecified parts of face, Basal cell carcinoma of skin of other parts of face, Squamous cell carcinoma of skin of unspecified parts of face, Squamous cell carcinoma of skin of other parts of face, Other specified malignant neoplasm of skin of unspecified parts of face, Other specified malignant neoplasm of skin of nose, Other specified malignant neoplasm of skin of other parts of face, Unspecified malignant neoplasm of overlapping sites of skin, Basal cell carcinoma of overlapping sites of skin, Squamous cell carcinoma of overlapping sites of skin, Other specified malignant neoplasm of overlapping sites of skin, Carcinoma in situ of oral cavity, unspecified site, Carcinoma in situ of labial mucosa and vermilion border, Carcinoma in situ of gingiva and edentulous alveolar ridge, Melanoma in situ of unspecified eyelid, including canthus, Melanoma in situ of right upper eyelid, including canthus, Melanoma in situ of right lower eyelid, including canthus, Melanoma in situ of left upper eyelid, including canthus, Melanoma in situ of left lower eyelid, including canthus, Melanoma in situ of unspecified ear and external auricular canal, Melanoma in situ of right ear and external auricular canal, Melanoma in situ of left ear and external auricular canal, Melanoma in situ of unspecified part of face, Carcinoma in situ of skin of unspecified eyelid, including canthus, Carcinoma in situ of skin of right upper eyelid, including canthus, Carcinoma in situ of skin of right lower eyelid, including canthus, Carcinoma in situ of skin of left upper eyelid, including canthus, Carcinoma in situ of skin of left lower eyelid, including canthus, Carcinoma in situ of skin of unspecified ear and external auricular canal, Carcinoma in situ of skin of right ear and external auricular canal, Carcinoma in situ of skin of left ear and external auricular canal, Carcinoma in situ of skin of unspecified part of face, Carcinoma in situ of skin of other parts of face, Some older versions have been archived.
